Advertisement

Advertisement

Tislelizumab Plus Chemotherapy for Recurrent/Metastatic Nasopharyngeal Cancer: RATIONALE-309
Posted: 05/04/2022
By: Sarah Campen, PharmD

Question 1 of 5

What kind of agent is tislelizumab?

Choose 1